hydroxyurea has been researched along with Psoriasis in 105 studies
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Literature is replete with reports on the therapeutic efficacy and toxicity of methotrexate or hydroxycarbamide for treating chronic plaque psoriasis but no comparative study on their efficacy/safety has been carried out." | 9.12 | Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study. ( Mahajan, VK; Ranjan, N; Shanker, V; Sharma, NL; Tegta, GR, 2007) |
| "Hydroxyurea is an effective treatment in chronic plaque psoriasis that is relatively simple to prescribe." | 8.80 | Use of hydroxyurea in psoriasis. ( Smith, CH, 1999) |
| "We report the use of a combination of the tumour necrosis factor alpha (TNF alpha) inhibitor infliximab and hydroxyurea to achieve control of disabling psoriasis and psoriatic arthritis." | 7.72 | Successful treatment of recalcitrant psoriasis with a combination of infliximab and hydroxyurea. ( Berth-Jones, J; Gach, JE, 2003) |
| "We report the case of an elderly woman who had been on hydroxyurea for long-standing widespread psoriasis." | 7.70 | Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis. ( Lanigan, SW; Varma, S, 1999) |
| "Eighty-five patients with extensive chronic plaque psoriasis, unresponsive to conventional topical therapy, were treated with long-term hydroxyurea in a dose of 0." | 7.67 | Hydroxyurea in the management of therapy resistant psoriasis. ( Cotterill, JA; Goodfield, MJ; Layton, AM; Sheehan-Dare, RA, 1989) |
| "Hydroxyurea has been rarely implicated as a cause of drug fever." | 7.66 | Fever caused by hydroxyurea. ( Bauernfeind, RA; Bauman, JL; Hartsough, N; Hasegawa, GR; Roden, R; Shulruff, S, 1981) |
| "A clinical trial study in the treatment of psoriasis was conducted in twenty three patients." | 6.78 | Comparative efficacy of hydroxyurea and methotrexate in treating psoriasis. ( Hazra, SC; Khan, SI; Khondker, L; Mahbub, MS, 2013) |
| " Growing considerations for this population in the literature include cutaneous reactions to common treatments such as hydroxyurea and clinical management of the intersection between sickle cell disease and conditions like plaque psoriasis." | 5.41 | Cutaneous manifestations of sickle cell disease: an updated review. ( Dick, A; Khachemoune, A; Schwartzman, G, 2023) |
| "Hydroxyurea is an effective, very safe but relatively slower acting alternative for patients with extensive CPP over the short-to-medium term." | 5.31 | Rediscovering hydroxyurea: its role in recalcitrant psoriasis. ( Kaur, I; Kumar, B; Saraswat, A, 2001) |
| "As we are treating selected psoriasis patients with low dose hydroxyurea we attempted to define the spectrum and chronology of dermatological adverse effects in this group of patients prospectively." | 5.31 | Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. ( Kaur, I; Kumar, B; Saraswat, A, 2002) |
| "Literature is replete with reports on the therapeutic efficacy and toxicity of methotrexate or hydroxycarbamide for treating chronic plaque psoriasis but no comparative study on their efficacy/safety has been carried out." | 5.12 | Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study. ( Mahajan, VK; Ranjan, N; Shanker, V; Sharma, NL; Tegta, GR, 2007) |
| "Hydroxyurea is an effective treatment in chronic plaque psoriasis that is relatively simple to prescribe." | 4.80 | Use of hydroxyurea in psoriasis. ( Smith, CH, 1999) |
| "Hydroxyurea's place in the scheme of psoriasis therapy has diminished in recent years." | 4.78 | Hydroxyurea therapy. ( Boyd, AS; Neldner, KH, 1991) |
| "Current concepts in the treatment of psoriasis are reviewed, including: traditional modalities of dithranol (anthralin), tar, and corticosteroids alone or in combination with other agents; phototherapy and photochemotherapy; experimental studies with the aromatic retinoid etretinate and related analogues; dialysis; and the potential use of hyperthermia." | 4.76 | Psoriasis. A review of recent advances in treatment. ( Farber, EM; Nall, L, 1984) |
| " Hydroxyurea, an antitumor systemic agent (a ribonucleoside diphosphate reductase inhibitor) used in the treatment of refractory psoriasis as well as in the variety of neoplastic disorders is known to cause brownish pigmentation of the nails but hydroxyurea induced blue lunula is very rare." | 3.72 | Blue lunula due to hydroxyurea. ( Jeevankumar, B; Thappa, DM, 2003) |
| "We report the use of a combination of the tumour necrosis factor alpha (TNF alpha) inhibitor infliximab and hydroxyurea to achieve control of disabling psoriasis and psoriatic arthritis." | 3.72 | Successful treatment of recalcitrant psoriasis with a combination of infliximab and hydroxyurea. ( Berth-Jones, J; Gach, JE, 2003) |
| "We report the case of an elderly woman who had been on hydroxyurea for long-standing widespread psoriasis." | 3.70 | Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis. ( Lanigan, SW; Varma, S, 1999) |
| "Eighty-five patients with extensive chronic plaque psoriasis, unresponsive to conventional topical therapy, were treated with long-term hydroxyurea in a dose of 0." | 3.67 | Hydroxyurea in the management of therapy resistant psoriasis. ( Cotterill, JA; Goodfield, MJ; Layton, AM; Sheehan-Dare, RA, 1989) |
| "Hydroxyurea has been rarely implicated as a cause of drug fever." | 3.66 | Fever caused by hydroxyurea. ( Bauernfeind, RA; Bauman, JL; Hartsough, N; Hasegawa, GR; Roden, R; Shulruff, S, 1981) |
| " It is postulated that the basic intrinsic abnormality of neutrophil function in psoriasis could be caused by a decreased cyclic AMP/cyclic GMP ratio, similar to the decreased cyclic AMP/cyclic GMP ratio found in the lesional epidermis of this disease." | 3.66 | Neutrophil chemotaxis in psoriasis. ( Bar-Eli, M; Callily, R; Cohen, H; Wahba, A, 1979) |
| "Hydroxyurea is an effective treatment for psoriasis but consistently produces macrocytosis in peripheral blood with a fall in haemoglobin levels and white cell counts." | 3.65 | Long-term effects of hydroxyurea in psoriases. ( Comaish, JS; Dahl, MG, 1972) |
| "A clinical trial study in the treatment of psoriasis was conducted in twenty three patients." | 2.78 | Comparative efficacy of hydroxyurea and methotrexate in treating psoriasis. ( Hazra, SC; Khan, SI; Khondker, L; Mahbub, MS, 2013) |
| "Many systemic agents are used in the treatment of psoriasis." | 2.42 | Current systemic therapies for psoriasis: where are we now? ( Kormeili, T; Lowe, NJ; Patnaik, R; Rizk, D; Yamauchi, PS, 2003) |
| "Psoriasis is a chronic, relapsing dermatosis characterised by scaling, erythema, and less commonly pustulation." | 2.36 | Psoriasis: current concepts in management. ( Comaish, JS; Hodge, L, 1977) |
| "Traditional psoriasis therapies are associated with significant adverse events in some patients despite toxicity-sparing approaches such as combination therapy." | 1.33 | Adverse events from systemic therapies for psoriasis are common in clinical practice. ( Balkrishnan, R; Camacho, F; Crane, MM; Feldman, SR; Fleischer, AB; Higgins, KB; Pearce, DJ; Stealey, KH, 2006) |
| "Hydroxyurea is an effective, very safe but relatively slower acting alternative for patients with extensive CPP over the short-to-medium term." | 1.31 | Rediscovering hydroxyurea: its role in recalcitrant psoriasis. ( Kaur, I; Kumar, B; Saraswat, A, 2001) |
| "As we are treating selected psoriasis patients with low dose hydroxyurea we attempted to define the spectrum and chronology of dermatological adverse effects in this group of patients prospectively." | 1.31 | Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. ( Kaur, I; Kumar, B; Saraswat, A, 2002) |
| "In considering specific treatment for psoriasis, cost analyses, including appropriate laboratory and other specialized evaluations, must be taken into account." | 1.29 | The annual cost of psoriasis. ( Harrison, PE; Menter, A; Morris, LF; Phillips, CM; Sander, HM, 1993) |
| "Recently the treatment of psoriasis with vitamin D3, its metabolites or analogues, has been reported to be clinically effective and free from side effects." | 1.28 | Epidermal keratin levels during oral 1-alpha-hydroxyvitamin D3 treatment for psoriasis. ( Cunliffe, WJ; Holland, DB; Roberts, SG; West, MR; Wood, EJ, 1989) |
| "Multiple lesions of Bowen's disease and squamous cell carcinoma on the penis and pubic areas developed in a 32-year-old patient with psoriasis who was undergoing treatment with psoralen and long-wave ultraviolet radiation (PUVA)." | 1.26 | Bowen's disease and squamous cell carcinoma. Occurrence in a patient with psoriasis after topical, systemic, and PUVA therapy. ( Tam, DW; Urbach, F; Van Scott, EJ, 1979) |
| "The chemotherapy of psoriasis is reviewed in 246 patients from 1964 to 1974 treated with methotrexate, 92 patients from 1971 to 1974 with hydroxyurea, and 36 patients from 1972 to 1974 with azaribine." | 1.26 | Chemotherapy of psoriasis: ten years of experience. ( Moschella, SL, 1976) |
| "Psoriasis is a autosomal hereditary disease of the skin, which has been treated with a great number of possibly carcinogenic substances." | 1.25 | [Excision repair in lymphocytes of psoriasis (author's transl)]. ( Bohnert, E; Jung, EG, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 75 (71.43) | 18.7374 |
| 1990's | 14 (13.33) | 18.2507 |
| 2000's | 11 (10.48) | 29.6817 |
| 2010's | 4 (3.81) | 24.3611 |
| 2020's | 1 (0.95) | 2.80 |
| Authors | Studies |
|---|---|
| Dick, A | 3 |
| Schwartzman, G | 3 |
| Khachemoune, A | 3 |
| Toh, JJ | 1 |
| Lim, YL | 1 |
| Yew, YW | 1 |
| Narang, T | 1 |
| Kumar, S | 1 |
| Handa, S | 1 |
| Dogra, S | 1 |
| Mahbub, MS | 1 |
| Khondker, L | 1 |
| Khan, SI | 1 |
| Hazra, SC | 1 |
| Kelly, JB | 1 |
| Foley, P | 1 |
| Strober, BE | 2 |
| Yamauchi, PS | 1 |
| Rizk, D | 1 |
| Kormeili, T | 1 |
| Patnaik, R | 1 |
| Lowe, NJ | 1 |
| Jeevankumar, B | 1 |
| Thappa, DM | 1 |
| Gach, JE | 1 |
| Berth-Jones, J | 1 |
| Siu, K | 1 |
| Menon, K | 1 |
| Damasiewicz-Bodzek, A | 1 |
| Kos-Kudła, B | 1 |
| Suwała-Jurczyk, B | 1 |
| Pearce, DJ | 1 |
| Higgins, KB | 1 |
| Stealey, KH | 1 |
| Balkrishnan, R | 1 |
| Crane, MM | 1 |
| Camacho, F | 1 |
| Fleischer, AB | 1 |
| Feldman, SR | 1 |
| Ranjan, N | 1 |
| Sharma, NL | 1 |
| Shanker, V | 1 |
| Mahajan, VK | 1 |
| Tegta, GR | 1 |
| Farber, EM | 2 |
| Nall, L | 1 |
| Champion, RH | 2 |
| McDonald, CJ | 5 |
| de Bast, C | 1 |
| Oleffe, J | 1 |
| De Coninck, A | 1 |
| Van Opdenbosch, L | 1 |
| Heddle, R | 1 |
| Calvert, AF | 1 |
| Novotný, F | 1 |
| Bauman, JL | 1 |
| Shulruff, S | 1 |
| Hasegawa, GR | 1 |
| Roden, R | 1 |
| Hartsough, N | 1 |
| Bauernfeind, RA | 1 |
| Ford-Hutchinson, AW | 1 |
| Layton, AM | 2 |
| Cotterill, JA | 2 |
| Tomlinson, IW | 1 |
| Sander, HM | 1 |
| Morris, LF | 1 |
| Phillips, CM | 1 |
| Harrison, PE | 1 |
| Menter, A | 1 |
| Zachariae, H | 1 |
| Heickendorff, L | 1 |
| Bjerring, P | 1 |
| Kirby, B | 3 |
| Rogers, S | 2 |
| Santais, MC | 1 |
| Callens, E | 1 |
| Djebbar, R | 1 |
| Ruff, F | 1 |
| Harrison, PV | 1 |
| Smith, CH | 1 |
| Varma, S | 1 |
| Lanigan, SW | 1 |
| Reynolds, N | 1 |
| Schwarze, HP | 1 |
| Loche, F | 1 |
| Kuchta, J | 1 |
| Bazex, J | 1 |
| Gibson, LE | 1 |
| Pittelkow, M | 1 |
| Griffiths, CE | 1 |
| Clark, CM | 1 |
| Chalmers, RJ | 1 |
| Li Wan Po, A | 1 |
| Williams, HC | 1 |
| Kumar, B | 2 |
| Saraswat, A | 2 |
| Kaur, I | 2 |
| Lindgren, S | 1 |
| Groth, O | 2 |
| Wahba, A | 1 |
| Cohen, H | 1 |
| Bar-Eli, M | 1 |
| Callily, R | 1 |
| Zackheim, HS | 2 |
| Nikitina, MN | 1 |
| Makashev, TK | 1 |
| Fadeeva, VI | 1 |
| Fedorovskaia, RF | 1 |
| Hodge, L | 1 |
| Comaish, JS | 2 |
| Tam, DW | 1 |
| Van Scott, EJ | 1 |
| Urbach, F | 1 |
| Watson, W | 1 |
| Klem, EB | 1 |
| Wohlrab, W | 1 |
| Zaumseil, RP | 2 |
| Pearlman, D | 1 |
| Abel, EA | 1 |
| Rees, RB | 1 |
| Loeffel, ED | 1 |
| Borisenko, KK | 2 |
| Kriazheva, SS | 1 |
| Folan, DW | 1 |
| Moschella, SL | 2 |
| Bergstresser, PR | 1 |
| Schreiber, SH | 1 |
| Weinstein, GD | 1 |
| Ruszczak, Z | 2 |
| Rollier, R | 1 |
| Woofter, JC | 1 |
| Anderson, PC | 1 |
| Baker, H | 1 |
| Bohnert, E | 1 |
| Jung, EG | 1 |
| Boyd, AS | 1 |
| Neldner, KH | 1 |
| Wolverton, SE | 1 |
| Holland, DB | 2 |
| Wood, EJ | 2 |
| Roberts, SG | 1 |
| West, MR | 1 |
| Cunliffe, WJ | 2 |
| Turner, DM | 1 |
| Barnhill, RL | 1 |
| Wiles, JC | 1 |
| Sheehan-Dare, RA | 1 |
| Goodfield, MJ | 1 |
| Niczyporuk, W | 1 |
| Skarzyński, J | 1 |
| Taube, KM | 1 |
| Sparks, MK | 1 |
| Moshell, AN | 1 |
| Nigra, TP | 1 |
| Yarbro, JW | 4 |
| Yu, KY | 1 |
| Ottolenghi, F | 2 |
| Andreassi, L | 2 |
| Hunter, GA | 1 |
| Simmons, IJ | 1 |
| Thomas, BM | 1 |
| Weber, G | 1 |
| Stetter, H | 1 |
| Braverman, IM | 1 |
| Cohen, I | 1 |
| O'Keefe, E | 1 |
| Smith, C | 2 |
| Gelfant, S | 1 |
| Rodionova, GV | 1 |
| Karasek, MA | 1 |
| Cox, AJ | 1 |
| Newbold, PC | 1 |
| Baden, HP | 1 |
| Pugliese, MM | 1 |
| Herzberg, JJ | 1 |
| Dahl, MG | 1 |
| Greenwald, MA | 1 |
| Sauer, GC | 1 |
| Leavell, UW | 4 |
| Mersack, IP | 1 |
| Rossi, A | 1 |
| Sebastio, L | 1 |
| Ventruto, V | 1 |
| Barrett, JL | 1 |
| Sayers, P | 1 |
| Spier, S | 2 |
| Solomon, LM | 2 |
| Esterly, NB | 2 |
| Fried, W | 2 |
| Roe, LD | 1 |
| Wilson, JW | 1 |
| Caccialanza, P | 1 |
| Finzi, AF | 1 |
| Touraine, R | 1 |
| Revuz, J | 1 |
| Tulliez, M | 1 |
| Stoughton, RB | 1 |
| Omura, GA | 1 |
| Stein, KM | 1 |
| Shelley, WB | 1 |
| Weinberg, RA | 1 |
| Rosten, M | 1 |
25 reviews available for hydroxyurea and Psoriasis
| Article | Year |
|---|---|
Cutaneous manifestations of sickle cell disease: an updated review.
Topics: Anemia, Sickle Cell; Humans; Hydroxyurea; Leg Ulcer; Psoriasis; Vascular Diseases | 2023 |
Cutaneous manifestations of sickle cell disease: an updated review.
Topics: Anemia, Sickle Cell; Humans; Hydroxyurea; Leg Ulcer; Psoriasis; Vascular Diseases | 2023 |
Cutaneous manifestations of sickle cell disease: an updated review.
Topics: Anemia, Sickle Cell; Humans; Hydroxyurea; Leg Ulcer; Psoriasis; Vascular Diseases | 2023 |
Cutaneous manifestations of sickle cell disease: an updated review.
Topics: Anemia, Sickle Cell; Humans; Hydroxyurea; Leg Ulcer; Psoriasis; Vascular Diseases | 2023 |
Cutaneous manifestations of sickle cell disease: an updated review.
Topics: Anemia, Sickle Cell; Humans; Hydroxyurea; Leg Ulcer; Psoriasis; Vascular Diseases | 2023 |
Cutaneous manifestations of sickle cell disease: an updated review.
Topics: Anemia, Sickle Cell; Humans; Hydroxyurea; Leg Ulcer; Psoriasis; Vascular Diseases | 2023 |
Cutaneous manifestations of sickle cell disease: an updated review.
Topics: Anemia, Sickle Cell; Humans; Hydroxyurea; Leg Ulcer; Psoriasis; Vascular Diseases | 2023 |
Cutaneous manifestations of sickle cell disease: an updated review.
Topics: Anemia, Sickle Cell; Humans; Hydroxyurea; Leg Ulcer; Psoriasis; Vascular Diseases | 2023 |
Cutaneous manifestations of sickle cell disease: an updated review.
Topics: Anemia, Sickle Cell; Humans; Hydroxyurea; Leg Ulcer; Psoriasis; Vascular Diseases | 2023 |
Current and future oral systemic therapies for psoriasis.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Cyclosporine; Fumarates; Humans | 2015 |
Current systemic therapies for psoriasis: where are we now?
Topics: Acitretin; Antineoplastic Agents; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Huma | 2003 |
Conventional systemic agents for psoriasis. A systematic review.
Topics: Acitretin; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicin | 2006 |
Psoriasis. A review of recent advances in treatment.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Coal Tar; Glucocorticoids; Humans; Hyd | 1984 |
Psoriasis and its treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Humans; Hydroxyurea; Methotrexate; Midd | 1981 |
International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication no. 6: do treatments available for psoriasis patients carry a genetic or carcinogenic risk?
Topics: Anthralin; Azathioprine; Carcinogens; Coal Tar; Humans; Hydroxyurea; Methotrexate; Mutagenicity Test | 1981 |
The uses of systemic chemotherapeutic agents in psoriasis.
Topics: Administration, Topical; Anthralin; Azathioprine; Azauridine; Chemical Phenomena; Chemistry; Humans; | 1981 |
Leukotriene antagonists and inhibitors: clinical applications.
Topics: Animals; Asthma; Glomerulonephritis; Humans; Hydroxyurea; Indoles; Inflammatory Bowel Diseases; Leuk | 1995 |
[Potential importance of antileukotrienes in the treatment of asthma and other inflammatory diseases: apropos of a new pharmacological class].
Topics: Acetophenones; Adult; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthr | 1998 |
Use of hydroxyurea in psoriasis.
Topics: Humans; Hydroxyurea; Nucleic Acid Synthesis Inhibitors; Psoriasis | 1999 |
A systematic review of treatments for severe psoriasis.
Topics: Antineoplastic Agents; Antirheumatic Agents; Fumarates; Humans; Hydroxyurea; Photochemotherapy; Phot | 2000 |
Psoriasis: current concepts in management.
Topics: Administration, Topical; Adrenal Cortex Hormones; Age Factors; Anthralin; Ficusin; Glycogen; Hair; H | 1977 |
An appraisal of current systemic chemotherapy for psoriasis.
Topics: Alkylating Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azauridine; Cell Division | 1976 |
Psoriasis: a review. II.
Topics: Adrenal Cortex Hormones; Anthralin; Azathioprine; Azauridine; Fluorouracil; Humans; Hydroxyurea; Lom | 1975 |
Chemotherapy of psoriasis.
Topics: Azauridine; Central Nervous System; Digestive System; Hematopoietic System; Humans; Hydroxyurea; Liv | 1975 |
Hydroxyurea therapy.
Topics: Humans; Hydroxyurea; Psoriasis | 1991 |
Guidelines for management of patients with psoriasis. Workshop of the Research Unit of the Royal College of Physicians of London; Department of Dermatology, University of Glasgow; British Association of Dermatologists.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporins; Humans; Hydroxyurea; Methotrexate; Phototherapy | 1991 |
Psoriasis.
Topics: Etretinate; Humans; Hydroxyurea; Methotrexate; Psoriasis; PUVA Therapy; Skin; Steroids; Ultraviolet | 1986 |
[Some developments in psoriasis research abroad].
Topics: Aza Compounds; Female; Humans; Hydroxyurea; Male; Mechlorethamine; Methotrexate; Psoriasis; Uridine | 1974 |
Antimetabolites and psoriasis.
Topics: Adrenal Cortex Hormones; Animals; Antimetabolites; Arsenic; Humans; Hydroxyurea; Methotrexate; Mice; | 1972 |
Psoriasis.
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Antimetabolites; Child; Female; | 1973 |
[Immunosuppressive drugs in the treatment of diseases belonging to the psoriasis group].
Topics: Administration, Oral; Adrenal Cortex Hormones; Autoantibodies; Humans; Hydroxyurea; Immunosuppressiv | 1974 |
Psoriasis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Antimetabolites; Aza Compounds; Glucocorticoids; | 1974 |
[Cytostatic drugs in the therapy of psoriasis].
Topics: Alkylating Agents; Aminopterin; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Humans; | 1971 |
6 trials available for hydroxyurea and Psoriasis
| Article | Year |
|---|---|
Comparative efficacy of hydroxyurea and methotrexate in treating psoriasis.
Topics: Adolescent; Adult; Bangladesh; Dermatologic Agents; Female; Humans; Hydroxyurea; Male; Methotrexate; | 2013 |
Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Dermatologic Agents; Drug Administration Schedule; Fe | 2007 |
Treatment of psoriasis with 6-aminonicotinamide.
Topics: Acid-Base Equilibrium; Administration, Oral; Administration, Topical; Adult; Aged; Amines; Biopsy; C | 1975 |
A clinical trial of hydroxyurea for psoriasis.
Topics: Adult; Aged; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Hydroxyurea; Male; Methotrexate; | 1972 |
Topical hydroxyurea and psoriasis.
Topics: Biopsy; Clinical Trials as Topic; Female; Humans; Hydroxyurea; Keratosis; Male; Mitosis; Plastics; P | 1972 |
Hydroxyurea. A new treatment for psoriasis.
Topics: Adult; Aged; Biopsy; Blood Cell Count; Clinical Trials as Topic; Female; Humans; Hydroxyurea; Male; | 1970 |
74 other studies available for hydroxyurea and Psoriasis
| Article | Year |
|---|---|
Characteristics and Management of Autoimmune Bullous Disease in Psoriasis Patients.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Aged, 80 and over; Autoimmune Diseases | 2019 |
Hydroxyurea and acitretin as a novel combination therapy in severe plaque psoriasis.
Topics: Acitretin; Administration, Oral; Adult; Drug Administration Schedule; Drug Therapy, Combination; Fem | 2018 |
Blue lunula due to hydroxyurea.
Topics: Antineoplastic Agents; Humans; Hydroxyurea; Male; Middle Aged; Nail Diseases; Psoriasis | 2003 |
Successful treatment of recalcitrant psoriasis with a combination of infliximab and hydroxyurea.
Topics: Administration, Oral; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Administration | 2003 |
The effect of various methods of psoriasis treatment on somatotrophin axis hormones in serum.
Topics: Acitretin; Adult; Case-Control Studies; Female; Growth Hormone; Humans; Hydroxyurea; Insulin-Like Gr | 2006 |
Adverse events from systemic therapies for psoriasis are common in clinical practice.
Topics: Adult; Aged; Biological Products; Cyclosporine; Dermatologic Agents; Female; Humans; Hydroxyurea; Ma | 2006 |
[Persistent psoriasis: failure of PUVA and peritoneal dialysis-response to methotrexate and hydroxyurea].
Topics: Aged; Female; Humans; Hydroxyurea; Methotrexate; Peritoneal Dialysis; Photochemotherapy; Psoriasis; | 1982 |
Hydroxyurea induced hepatitis.
Topics: Chemical and Drug Induced Liver Injury; Humans; Hydroxyurea; Male; Middle Aged; Psoriasis | 1980 |
[Severe psoriasis treated with hydroxyurea (author's transl)].
Topics: Adult; Female; Humans; Hydroxyurea; Male; Psoriasis | 1980 |
Fever caused by hydroxyurea.
Topics: Aspirin; Female; Fever; Humans; Hydroxyurea; Middle Aged; Psoriasis; Recurrence | 1981 |
Hydroxyurea-induced lupus erythematosus.
Topics: Female; Humans; Hydroxyurea; Lupus Erythematosus, Systemic; Middle Aged; Psoriasis | 1994 |
The annual cost of psoriasis.
Topics: Adult; Cyclosporine; Etretinate; Female; Health Care Costs; Humans; Hydroxyurea; Male; Methotrexate; | 1993 |
Plasma endothelin in psoriasis: possible relations to therapy and toxicity.
Topics: Acitretin; Cyclosporine; Endothelins; Humans; Hydroxyurea; Keratolytic Agents; Methotrexate; Psorias | 1996 |
Hydroxyurea-induced dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea.
Topics: Antineoplastic Agents; Dermatologic Agents; Dermatomyositis; Hematologic Neoplasms; Humans; Hydroxyu | 1998 |
Combination low-dose cyclosporin (Neoral) and hydroxyurea for severe recalcitrant psoriasis.
Topics: Aged; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Mal | 1999 |
Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis.
Topics: Aged; Aged, 80 and over; Dermatologic Agents; Dermatomyositis; Drug Eruptions; Female; Humans; Hydro | 1999 |
Hydroxyurea in psoriasis.
Topics: Dermatologic Agents; Humans; Hydroxyurea; Pamphlets; Psoriasis | 1999 |
Patient information sheet used at St John's Institute of Dermatology. HYDROXYUREA (Hydrea) Information Leaflet.
Topics: Dermatologic Agents; Drug Labeling; Humans; Hydroxyurea; Psoriasis | 1999 |
Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis.
Topics: Drug Eruptions; Humans; Hydroxyurea; Leg Ulcer; Psoriasis | 2000 |
Rediscovering hydroxyurea: its role in recalcitrant psoriasis.
Topics: Adult; Enzyme Inhibitors; Female; Humans; Hydroxyurea; Male; Middle Aged; Prospective Studies; Psori | 2001 |
Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients.
Topics: Adult; Aged; Drug Eruptions; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Hydroxyurea; Icht | 2002 |
Generalized pustular psoriasis. A report on thirteen patients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Bacterial Agents; Female; Follow-Up Studies; Humans; Hydr | 1976 |
Neutrophil chemotaxis in psoriasis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Chemotaxis, Leukocyte; Child; Cyclic AMP; Cyclic GMP; | 1979 |
[Experience with the use of biosupresin (hydroxyurea) in the treatment of various forms of psoriasis].
Topics: Adolescent; Adult; Arthritis; Child; Child, Preschool; Dermatitis, Exfoliative; Drug Evaluation; Hum | 1975 |
Bowen's disease and squamous cell carcinoma. Occurrence in a patient with psoriasis after topical, systemic, and PUVA therapy.
Topics: Adult; Carcinoma, Squamous Cell; Coal Tar; Cocarcinogenesis; Glucocorticoids; Humans; Hydroxyurea; M | 1979 |
Psoriasis: topical and systemic therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Coal Tar; Humans; Hydroxyurea; Keratoly | 1979 |
When to try antineoplastic agents in psoriasis.
Topics: Antineoplastic Agents; Azauridine; Humans; Hydroxyurea; Kidney Function Tests; Liver Function Tests; | 1977 |
[Cytostatic therapy of psoriasis].
Topics: Antineoplastic Agents; Azauridine; Humans; Hydroxyurea; Methotrexate; Psoriasis | 1979 |
Effects of antipsoriasis drugs and metabolic inhibitors on the growth of epidermal cells in culture.
Topics: Animals; Anthralin; Antimetabolites; Azauridine; Cell Division; Cells, Cultured; Cycloheximide; Cyta | 1978 |
[Effectiveness of cytostatic agents on the psoriatic epidermal cell (author's transl)].
Topics: Antineoplastic Agents; Female; Humans; Hydroxyurea; Male; Methotrexate; Psoriasis | 1978 |
Psoriasis: clinical aspects and management.
Topics: Administration, Topical; Age Factors; Azauridine; Fluorouracil; Humans; Hydroxyurea; Mechlorethamine | 1976 |
The true heartbreaks of psoriasis.
Topics: Humans; Hydroxyurea; Methotrexate; Psoriasis; Ultraviolet Therapy | 1977 |
[Genetic control in administration of hydroxyurea to patients with psoriasis].
Topics: Adult; Humans; Hydroxyurea; Middle Aged; Psoriasis; Sex Chromatin; Time Factors | 1977 |
Severe reaction to hydroxyurea.
Topics: Drug Hypersensitivity; Humans; Hydroxyurea; Male; Middle Aged; Psoriasis; Thrombocytopenia | 1977 |
Chemotherapy of psoriasis: ten years of experience.
Topics: Azauridine; Humans; Hydroxyurea; Methotrexate; Psoriasis; Retrospective Studies | 1976 |
Systemic chemotherapy for psoriasis: a national survey.
Topics: Adult; Azauridine; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Utiliz | 1976 |
[Immunosuppressive agents in the treatment of psoriasis].
Topics: Azauridine; Cyclophosphamide; Drug Evaluation; Humans; Hydroxyurea; Immunosuppressive Agents; Methot | 1976 |
[Our therapeutic experiences with psoriasis in Morocco].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Child; Drug Therapy, Combination; Female; Fluocinonide; | 1976 |
Megaloblastic anemia in the management of severe psoriasis.
Topics: Anemia, Macrocytic; Anemia, Megaloblastic; Female; Humans; Hydroxyurea; Methotrexate; Middle Aged; P | 1975 |
[Excision repair in lymphocytes of psoriasis (author's transl)].
Topics: Adult; Carcinogens; DNA Repair; Female; Humans; Hydroxyurea; In Vitro Techniques; Lymphocytes; Male; | 1975 |
Systemic drug therapy for psoriasis. The most critical issues.
Topics: Cyclosporins; Humans; Hydroxyurea; Methotrexate; Psoriasis | 1991 |
Epidermal keratin levels during oral 1-alpha-hydroxyvitamin D3 treatment for psoriasis.
Topics: Anthralin; Calcium; Cell Differentiation; Cell Division; Densitometry; Electrophoresis, Polyacrylami | 1989 |
Keratin gene expression during the resolution of psoriatic plaques: effect of dithranol, PUVA, etretinate and hydroxyurea regimens.
Topics: Anthralin; Densitometry; Electrophoresis; Epidermis; Etretinate; Female; Gene Expression; Humans; Hy | 1989 |
Malignant melanoma associated with multiple therapies for psoriasis.
Topics: Adrenal Cortex Hormones; Adult; Coal Tar; Humans; Hydroxyurea; Male; Melanoma; Methotrexate; Photoch | 1989 |
Hydroxyurea in the management of therapy resistant psoriasis.
Topics: Adult; Aged; Anemia; Female; Hemorrhagic Disorders; Humans; Hydroxyurea; Male; Middle Aged; Psoriasi | 1989 |
Hydroxyurea in the treatment of psoriasis.
Topics: Cell Division; DNA Replication; Humans; Hydroxyurea; Psoriasis | 1986 |
[Coexistence of psoriasis vulgaris and porphyria cutanea tarda in a patient treated with hydroxycarbamid. Case report].
Topics: Humans; Hydroxyurea; Male; Middle Aged; Porphyrias; Psoriasis; Skin Diseases | 1986 |
Hydroxyurea and pain in psoriatic lesions during ultraviolet-B radiation.
Topics: Aged; Female; Humans; Hydroxyurea; Middle Aged; Pain; Photochemotherapy; Psoriasis | 1985 |
Cutaneous uses of the antiproliferative drugs.
Topics: Administration, Topical; Antimetabolites; Azauridine; Bleomycin; Chemical and Drug Induced Liver Inj | 1974 |
Hydroxyurea in the treatment of refractory psoriasis.
Topics: Female; Humans; Hydroxyurea; Male; Middle Aged; Psoriasis | 1969 |
[Limitations and risks of therapy of psoriasis with amethopterin and hydroxyurea].
Topics: Adult; Aged; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Chromosome Aberrat | 1971 |
[An unknown metabolic disturbance of psoriasis vulgaris (author's transl)].
Topics: Adolescent; Adult; Dermatitis, Exfoliative; Dietary Proteins; Female; Humans; Hydroxyurea; Lymphocyt | 1974 |
Metabolic and ultrastructural studies in a patient with pustular psoriasis (von Zumbusch).
Topics: Adrenal Cortex Hormones; Blood Protein Disorders; Capillaries; Colchicine; Epithelial Cells; Estroge | 1972 |
Effects of methotrexate and hydroxyurea on psoriatic epidermis. Preferential cytotoxic effects on psoriatic epidermis.
Topics: Administration, Oral; Administration, Topical; Biopsy; Dose-Response Relationship, Drug; Humans; Hyd | 1974 |
[Hydroxyurea in the treatment of psoriasis].
Topics: Adult; Drug Evaluation; Female; Humans; Hydroxyurea; Male; Middle Aged; Psoriasis | 1974 |
[Proceedings: Immunosuppression and treatment of psoriasis using cytostatic agents].
Topics: Aged; Antineoplastic Agents; Azathioprine; Bibliographies as Topic; Chemical and Drug Induced Liver | 1973 |
Long-term effects of hydroxyurea in psoriases.
Topics: Adult; Aged; Biopsy; Erythrocytes, Abnormal; Female; Hemoglobinometry; Humans; Hydroxyurea; Leukocyt | 1972 |
Psoriasis with hydroxyurea. An 18-month study of 60 patients.
Topics: Adult; Aged; Anemia; Chemical and Drug Induced Liver Injury; Drug Resistance; Female; Humans; Hydrox | 1973 |
Combined methotrexate and hydroxyurea therapy for psoriasis.
Topics: Administration, Oral; Adult; Arthritis; Drug Hypersensitivity; Female; Humans; Hydroxyurea; Male; Me | 1973 |
Survey of the treatment of psoriasis with hydroxyurea.
Topics: Humans; Hydroxyurea; Psoriasis | 1973 |
Generalized pustular psoriasis.
Topics: Adrenal Cortex Hormones; Humans; Hydroxyurea; Methotrexate; Psoriasis | 1973 |
[Chromosome study in 14 psoriatic patients treated with hydroxyurea and azathioprine].
Topics: Adult; Azathioprine; Chromosomes; Humans; Hydroxyurea; Karyotyping; Male; Middle Aged; Mutagens; Pso | 1973 |
Unsuccessful fluorouracil treatment of recalcitrant pustular psoriasis.
Topics: Adult; Fluorouracil; Humans; Hydroxyurea; Male; Prednisone; Psoriasis | 1973 |
Hydroxyurea and macrocytosis.
Topics: Adult; Anemia, Macrocytic; Bone Marrow; Female; Folic Acid; Humans; Hydroxyurea; Leukopenia; Male; M | 1973 |
Hydroxyurea therapy.
Topics: Adult; Humans; Hydroxyurea; Male; Psoriasis; Purpura; Skin | 1973 |
Psoriasis and hydroxyurea.
Topics: Erythrocyte Count; Folic Acid; Folic Acid Deficiency; Hemoglobins; Humans; Hydroxyurea; Psoriasis | 1972 |
[Treatment of psoriasis with hydroxyurea].
Topics: Adult; Aged; Female; Humans; Hydroxyurea; Male; Methotrexate; Middle Aged; Psoriasis | 1972 |
Effect of hydroxyurea and cytarabine on rodent epidermal cells.
Topics: Animals; Animals, Newborn; Cell Nucleus; Cytarabine; Depression, Chemical; DNA Replication; Hydroxyu | 1971 |
Treatment of psoriasis by hydroxyurea.
Topics: Blood Platelets; Dosage Forms; Humans; Hydroxyurea; Leukocytes; Psoriasis | 1971 |
Hydroxyurea and macrocytosis.
Topics: Anemia, Macrocytic; Folic Acid Deficiency; Humans; Hydroxyurea; Psoriasis | 1971 |
Hydroxyurea: a new agent for the management of refractory psoriasis.
Topics: Aged; Humans; Hydroxyurea; Male; Psoriasis | 1969 |
Psoriasis.
Topics: Antineoplastic Agents; Humans; Hydroxyurea; Psoriasis | 1970 |
Hydroxyurea in the treatment of pustular psoriasis.
Topics: Administration, Oral; Adolescent; Female; Fever; Humans; Hydroxyurea; Leukocyte Count; Leukocytosis; | 1971 |
Hydroxyurea: a new antimetabolite in the treatment of psoriasis.
Topics: Adolescent; Adult; Blood Cell Count; Blood Platelets; Chronic Disease; Female; Hemoglobinometry; Hum | 1971 |